Abstract
This paper aims to review biologics in allergic rhinitis (AR). Biologic agents of Omalizumab, Dupilumab, Mepolizumab, Reslizumab, and Benralizumab are......
小提示:本篇文献需要登录阅读全文,点击跳转登录